Host response to transmissible Pseudomonas aeruginosa

Reid D.W., Champion A., Bradbury R., Kirov S.M.

Source: Eur Respir J 2004; 23: 493-494
Journal Issue: March
Disease area: Respiratory infections

PDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Reid D.W., Champion A., Bradbury R., Kirov S.M.. Host response to transmissible Pseudomonas aeruginosa. Eur Respir J 2004; 23: 493-494

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated?
Source: Eur Respir J 2011; 38: 1483-1486
Year: 2011


The impact of testosterone on Pseudomonas aeruginosa pathogenicity and antimicrobial susceptibility
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018

Respiratory commensal streptococcus spp do not modulate the outcome of pseudomonas aeruginosa infection in vivo
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016

Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006

Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa
Source: Eur Respir J 2011; 38: 409-414
Year: 2011



Dental units as infection sources of Pseudomonas aeruginosa
Source: Eur Respir J 2008; 32: 1122-1123
Year: 2008


Pseudomonas aeruginosa and cyanide production
Source: Eur Respir J 2011; 37: 482-483
Year: 2011


Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD.
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020




Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017

The role of ceramide in the host defense against pseudomonas aeruginosa infection
Source: Eur Respir J 2006; 28: Suppl. 50, 486s
Year: 2006

Characterization of the resistance mechanisms to carbapenems and virulence genes in Pseudomonas aeruginosa strains from children with cystic fibrosis.
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021


Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021


Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018


Macrolide resistance in Pseudomonas aeruginosa: implications for practice
Source: Eur Respir J, 49 (5) 1700689; 10.1183/13993003.00689-2017
Year: 2017



Pulmonary infections with pseudomonas aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 642s
Year: 2004

Pseudomonas aeruginosa from CF airways uses various strategies to outcompete staphylococcus aureus
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016


Pseudomonas aeruginosa and legionella pneumophilia in water of dental units
Source: Eur Respir J 2006; 28: Suppl. 50, 486s
Year: 2006

Molecular mechanisms and virulence of colistin-resistant klebsiella pneumoniae
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016


Streptococcus pneumoniae inhibits Pseudomonas aeruginosa growth on nasal human epithelium in vitro
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018